Research ArticleCancer Immunotherapy

GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells

See allHide authors and affiliations

Science Translational Medicine  27 Mar 2019:
Vol. 11, Issue 485, eaau7746
DOI: 10.1126/scitranslmed.aau7746

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article